These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
474 related articles for article (PubMed ID: 33517686)
21. Mouse microglia express unique miRNA-mRNA networks to facilitate age-specific functions in the developing central nervous system. Walsh AD; Stone S; Freytag S; Aprico A; Kilpatrick TJ; Ansell BRE; Binder MD Commun Biol; 2023 May; 6(1):555. PubMed ID: 37217597 [TBL] [Abstract][Full Text] [Related]
22. Promotion of microglial phagocytosis by tuftsin stimulates remyelination in experimental autoimmune encephalomyelitis. Bao Z; Hao J; Li Y; Feng F Mol Med Rep; 2019 Dec; 20(6):5190-5196. PubMed ID: 31702807 [TBL] [Abstract][Full Text] [Related]
23. Microglial autophagy-associated phagocytosis is essential for recovery from neuroinflammation. Berglund R; Guerreiro-Cacais AO; Adzemovic MZ; Zeitelhofer M; Lund H; Ewing E; Ruhrmann S; Nutma E; Parsa R; Thessen-Hedreul M; Amor S; Harris RA; Olsson T; Jagodic M Sci Immunol; 2020 Oct; 5(52):. PubMed ID: 33067381 [TBL] [Abstract][Full Text] [Related]
24. Stem Cell-Derived Exosomal MicroRNAs as Novel Potential Approach for Multiple Sclerosis Treatment. Tahmasebi F; Asl ER; Vahidinia Z; Barati S Cell Mol Neurobiol; 2024 May; 44(1):44. PubMed ID: 38713302 [TBL] [Abstract][Full Text] [Related]
25. Targeting PKC in microglia to promote remyelination and repair in the CNS. Kim PM; Kornberg MD Curr Opin Pharmacol; 2022 Feb; 62():103-108. PubMed ID: 34965482 [TBL] [Abstract][Full Text] [Related]
26. The role of microRNAs involved in the disorder of blood-brain barrier in the pathogenesis of multiple sclerosis. Emami Nejad A; Mostafavi Zadeh SM; Nickho H; Sadoogh Abbasian A; Forouzan A; Ahmadlou M; Nedaeinia R; Shaverdi S; Manian M Front Immunol; 2023; 14():1281567. PubMed ID: 38193092 [TBL] [Abstract][Full Text] [Related]
27. The pro-remyelination properties of microglia in the central nervous system. Lloyd AF; Miron VE Nat Rev Neurol; 2019 Aug; 15(8):447-458. PubMed ID: 31256193 [TBL] [Abstract][Full Text] [Related]
28. CSF1R signaling is a regulator of pathogenesis in progressive MS. Hagan N; Kane JL; Grover D; Woodworth L; Madore C; Saleh J; Sancho J; Liu J; Li Y; Proto J; Zelic M; Mahan A; Kothe M; Scholte AA; Fitzgerald M; Gisevius B; Haghikia A; Butovsky O; Ofengeim D Cell Death Dis; 2020 Oct; 11(10):904. PubMed ID: 33097690 [TBL] [Abstract][Full Text] [Related]
29. Microglia in the context of multiple sclerosis. Zhang X; Chen F; Sun M; Wu N; Liu B; Yi X; Ge R; Fan X Front Neurol; 2023; 14():1157287. PubMed ID: 37360338 [TBL] [Abstract][Full Text] [Related]
30. High-Resolution Transcriptomic and Proteomic Profiling of Heterogeneity of Brain-Derived Microglia in Multiple Sclerosis. Miedema A; Wijering MHC; Eggen BJL; Kooistra SM Front Mol Neurosci; 2020; 13():583811. PubMed ID: 33192299 [TBL] [Abstract][Full Text] [Related]
31. Activation of FXR by ganoderic acid A promotes remyelination in multiple sclerosis via anti-inflammation and regeneration mechanism. Jia Y; Zhang D; Li H; Luo S; Xiao Y; Han L; Zhou F; Wang C; Feng L; Wang G; Wu P; Xiao C; Yu H; Du J; Bao H Biochem Pharmacol; 2021 Mar; 185():114422. PubMed ID: 33482151 [TBL] [Abstract][Full Text] [Related]
32. Dysregulated Network of miRNAs Involved in the Pathogenesis of Multiple Sclerosis. Dolati S; Marofi F; Babaloo Z; Aghebati-Maleki L; Roshangar L; Ahmadi M; Rikhtegar R; Yousefi M Biomed Pharmacother; 2018 Aug; 104():280-290. PubMed ID: 29775896 [TBL] [Abstract][Full Text] [Related]
33. Detrimental and protective action of microglial extracellular vesicles on myelin lesions: astrocyte involvement in remyelination failure. Lombardi M; Parolisi R; Scaroni F; Bonfanti E; Gualerzi A; Gabrielli M; Kerlero de Rosbo N; Uccelli A; Giussani P; Viani P; Garlanda C; Abbracchio MP; Chaabane L; Buffo A; Fumagalli M; Verderio C Acta Neuropathol; 2019 Dec; 138(6):987-1012. PubMed ID: 31363836 [TBL] [Abstract][Full Text] [Related]
34. Multifaceted involvement of microglia in gray matter pathology in multiple sclerosis. Tsouki F; Williams A Stem Cells; 2021 Aug; 39(8):993-1007. PubMed ID: 33754376 [TBL] [Abstract][Full Text] [Related]
35. Microglia: The Missing Link to Decipher and Therapeutically Control MS Progression? Geladaris A; Häusler D; Weber MS Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33801644 [TBL] [Abstract][Full Text] [Related]
36. Involvement of microRNA in microglia-mediated immune response. Guedes J; Cardoso AL; Pedroso de Lima MC Clin Dev Immunol; 2013; 2013():186872. PubMed ID: 23762086 [TBL] [Abstract][Full Text] [Related]
37. Meningeal inflammation in multiple sclerosis induces phenotypic changes in cortical microglia that differentially associate with neurodegeneration. van Olst L; Rodriguez-Mogeda C; Picon C; Kiljan S; James RE; Kamermans A; van der Pol SMA; Knoop L; Michailidou I; Drost E; Franssen M; Schenk GJ; Geurts JJG; Amor S; Mazarakis ND; van Horssen J; de Vries HE; Reynolds R; Witte ME Acta Neuropathol; 2021 Jun; 141(6):881-899. PubMed ID: 33779783 [TBL] [Abstract][Full Text] [Related]
38. Neuroinflammation in Parkinson's disease: focus on the relationship between miRNAs and microglia. Xu K; Li Y; Zhou Y; Zhang Y; Shi Y; Zhang C; Bai Y; Wang S Front Cell Neurosci; 2024; 18():1429977. PubMed ID: 39131043 [TBL] [Abstract][Full Text] [Related]
39. Preactive multiple sclerosis lesions offer novel clues for neuroprotective therapeutic strategies. van Noort JM; van den Elsen PJ; van Horssen J; Geurts JJ; van der Valk P; Amor S CNS Neurol Disord Drug Targets; 2011 Feb; 10(1):68-81. PubMed ID: 21143143 [TBL] [Abstract][Full Text] [Related]
40. Tissue-resident immune cells in the pathogenesis of multiple sclerosis. Tian J; Jiang L; Chen Z; Yuan Q; Liu C; He L; Jiang F; Rui K Inflamm Res; 2023 Mar; 72(3):363-372. PubMed ID: 36547688 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]